Aprea Therapeutics, Inc. (APRE): Total Liabilities

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Total Liabilities is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$3.20M
As of 2022-12-31
-30.1%
3-year compound annual growth
$15.41M2018-12-31: $4.87M2019-12-31: $9.36M2020-12-31: $15.41M2021-12-31: $7.32M2022-12-31: $3.20M$3.20M
2018-12-31 Total Liabilities (USD) 2022-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2022-12-31$3.20M-56.2%2023-03-30, Balance as of period end
2021-12-31$7.32M-52.5%2023-03-30, Balance as of period end
2020-12-31$15.41M+64.6%2022-03-15, Balance as of period end
2019-12-31$9.36M+92.4%2021-03-16, Balance as of period end
2018-12-31$4.87Mn/a2020-03-27, Balance as of period end